Jasmini Alagaratnam

822 total citations · 1 hit paper
23 papers, 270 citations indexed

About

Jasmini Alagaratnam is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Jasmini Alagaratnam has authored 23 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Virology and 9 papers in Emergency Medicine. Recurrent topics in Jasmini Alagaratnam's work include HIV/AIDS Research and Interventions (11 papers), HIV Research and Treatment (10 papers) and HIV-related health complications and treatments (9 papers). Jasmini Alagaratnam is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), HIV Research and Treatment (10 papers) and HIV-related health complications and treatments (9 papers). Jasmini Alagaratnam collaborates with scholars based in United Kingdom, Italy and Sweden. Jasmini Alagaratnam's co-authors include Alan Winston, Jonathan Underwood, Sarah Fidler, Henrik Zetterberg, Davide De Francesco, Paul Edison, Paola Cinque, Marta Boffito, Christoph Boesecke and Hylke Waalewijn and has published in prestigious journals such as The Journal of Infectious Diseases, Thorax and AIDS.

In The Last Decade

Jasmini Alagaratnam

20 papers receiving 268 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023

2023 75 citations Juan Ambrosioni, Laura Levi et al. HIV Medicine profile →

Peers

Jasmini Alagaratnam

VIROL

EPIDE

NEURO

Thorsten Rosenkranz Germany

F. Pau Italy

Kirsten Moffat Australia

Jake A. Robinson United States

F Pigorini Italy

Ana Rachel Léda United States

Thomas M. Gates Australia

Luxshimi Lal Australia

Sherrie Jean United States

J. McArthur United States

Thorsten Rosenkranz Germany

Jasmini Alagaratnam

97 ×0.8

174 ×2.0

VIROL

74 ×0.9

73 ×1.5

EPIDE

111 ×3.4

NEURO

Citations per year, relative to Jasmini Alagaratnam Jasmini Alagaratnam (= 1×) peers Thorsten Rosenkranz

Countries citing papers authored by Jasmini Alagaratnam

Since Specialization

Citations

This map shows the geographic impact of Jasmini Alagaratnam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmini Alagaratnam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmini Alagaratnam more than expected).

Fields of papers citing papers by Jasmini Alagaratnam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmini Alagaratnam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmini Alagaratnam. The network helps show where Jasmini Alagaratnam may publish in the future.

Co-authorship network of co-authors of Jasmini Alagaratnam

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmini Alagaratnam. A scholar is included among the top collaborators of Jasmini Alagaratnam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmini Alagaratnam. Jasmini Alagaratnam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ambrosioni, Juan, Laura Levi, Jasmini Alagaratnam, et al.. (2025). Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025. HIV Medicine. 27(1). 18–32.

Alagaratnam, Jasmini, Kathrin van Bremen, Georg M. N. Behrens, et al.. (2025). Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular disease. The Lancet HIV. 12(5). e382–e392. 5 indexed citations

Alagaratnam, Jasmini, Wolfgang Stöhr, Elizabeth Hamlyn, et al.. (2024). Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial. Journal of Virus Eradication. 10(2). 100381–100381. 1 indexed citations

Alagaratnam, Jasmini, Simon Dustan, Ruth Byrne, et al.. (2024). Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirine. AIDS. 39(1). 95–98. 3 indexed citations

Alagaratnam, Jasmini, Caroline Sabin, Lucy Garvey, et al.. (2023). Evaluating virological outcomes in people with HIV on stable antiretroviral therapy with reduced frequency of HIV viral load monitoring during the COVID‐19 pandemic. HIV Medicine. 24(7). 845–850. 4 indexed citations

Alagaratnam, Jasmini, Phillip Chan, Felicia C. Chow, et al.. (2023). Cognitive Health in Persons With Human Immunodeficiency Virus: The Impact of Early Treatment, Comorbidities, and Aging. The Journal of Infectious Diseases. 227(Supplement_1). S38–S47. 10 indexed citations

Khan, Maryam, Daniel Bradshaw, Colin Brown, et al.. (2023). Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays. Open Forum Infectious Diseases. 10(5). ofad108–ofad108. 1 indexed citations

Ambrosioni, Juan, Laura Levi, Jasmini Alagaratnam, et al.. (2023). Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023. HIV Medicine. 24(11). 1126–1136. 75 indexed citations breakdown →

Sharp, David, Magnus Gisslén, Henrik Zetterberg, et al.. (2023). Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms. Translational Psychiatry. 13(1). 190–190. 13 indexed citations

10.

Alagaratnam, Jasmini, Davide De Francesco, Henrik Zetterberg, et al.. (2021). Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study. Journal of NeuroVirology. 28(1). 54–63. 14 indexed citations

11.

Alagaratnam, Jasmini, Davide De Francesco, Jonathan Underwood, et al.. (2021). Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis. BMJ Neurology Open. 3(1). e000143–e000143. 74 indexed citations

12.

Zan, Valentina De, Jasmini Alagaratnam, Simonetta Gerevini, et al.. (2021). The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-series. AIDS. 35(14). 2341–2346. 15 indexed citations

13.

Alagaratnam, Jasmini, et al.. (2020). Objective and subjective rapid frailty screening tools in people with HIV. HIV Medicine. 22(2). 146–150. 6 indexed citations

14.

Alagaratnam, Jasmini, Helen Peters, Kate Francis, et al.. (2020). An observational study of initial HIV RNA decay following initiation of combination antiretroviral treatment during pregnancy. AIDS Research and Therapy. 17(1). 41–41.

15.

Toniolo, Sofia, Mara Cercignani, Borja Mora‐Peris, et al.. (2020). Changes in functional connectivity in people with HIV switching antiretroviral therapy. Journal of NeuroVirology. 26(5). 754–763. 8 indexed citations

16.

Vera, Jaime H., Margherita Bracchi, Jasmini Alagaratnam, et al.. (2019). Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART. Brain Sciences. 9(8). 195–195. 14 indexed citations

17.

Dhillon, Syra, Caroline Sabin, Jasmini Alagaratnam, et al.. (2019). Level of agreement between frequently used cardiovascular risk calculators in people living with HIV. HIV Medicine. 20(5). 347–352. 11 indexed citations

18.

Penchala, Sujan Dilly, Jasmini Alagaratnam, Alieu Amara, et al.. (2019). The development and validation of a novel LC–MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid. Biomedical Chromatography. 34(1). e4711–e4711. 1 indexed citations

19.

Sunder, Rani, et al.. (2011). Tay-Sach disease with "cherry-red spot"--first reported case in Malaysia.. PubMed. 66(5). 497–8. 2 indexed citations

20.

Alagaratnam, Jasmini. (2009). Esomeprazole does not improve asthma control. Thorax. 64(10). 915–915. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact